News | May 12, 2025
Aarti Drugs Ltd Q4 FY2025 consolidated PAT climbs to Rs. 62.86 Cr
The company has posted net profit of Rs.168.16 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs.168.16 crores for the Financial Year ended March 31, 2025
Integrated facility to deliver end-to-end, customized workflows across life sciences, diagnostics, and applied markets
The company has posted net profit of Rs. 582.01 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 158.71 crores for the Financial Year ended March 31, 2025
RPG Life Sciences has reported total income of Rs. 148.15 crores during the period ended March 31, 2025
The Q1 2025 also witnessed a successful launch of Allegra D
Vimta Labs has reported total income of Rs. 96.08 crores during the period ended March 31, 2025
Phesgo label expansion delivers on patients’ preference for at-home administration and is an important step in freeing up cancer care capacity in clinical settings
The company has posted net profit of Rs. 406.7 crores for the Financial Year ended March 31, 2025
Delivers robust earnings performance, successfully navigating a dynamic environment
Subscribe To Our Newsletter & Stay Updated
